Boston Scientific’s Promising Trial Outcomes and Market Expansion Drive Buy Rating
Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...
TD Cowen maintains Boston Scientific buy rating, $110 target
TD Cowen reiterated a Buy rating for Boston Scientific (NYSE:BSX) stock, maintaining a price target of $110.00. The stock, currently trading at $98.78, has shown remarkable momentum, reaching new ...
Boston Scientific price target raised to $110 from $100 at Bernstein
Bernstein raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps an Outperform rating on the shares as part of a ...